Abstract P3-01-07: Phase II trial of palbociclib with fulvestrant in individuals with hormone receptor-positive, HER2-negative metastatic breast cancer with disease progression after palbociclib with an aromatase inhibitor

Authors: Jessica J. Tao, Amanda L. Blackford, Raquel Nunes, Cristina I. Truica, Justin Mahosky, Mary Kate Jones, Nick C. Leasure, Terrence Cescon, Antonios Christou, Jeanine L. Werner, Rima Couzi, Karen L. Smith, Cesar Augusto Santa-Maria, Antonio C. Wolff, Vered Stearns

Published: 2023-03-02

DOI: 10.1158/1538-7445.sabcs22-p3-01-07

Source: Full article